What is WALGREENS BOOTS listed on the DOW JONES?
Walgreens Boots Alliance, Inc. is a notable company in the pharmaceutical sector that is part of the index Dow Jones, although it has the least impact with a weight of only 0.44%. Of American origin, this company is listed under the stock symbol WBA on the NASDAQ. Despite its weak influence on the index, it captures the attention of investors due to its fluctuating stock market performance. Currently, its price is trading at 17.85 USD, marking a slight increase of 0.46% from its previous price. In the past, Walgreens has even been the worst performing company on the Dow Jones on a given day, trading at $55.67, down 6.11%. In 2024, it holds a mentioned value of 9.361 in the market. Walgreens was included in the Dow Jones index in June 2018, replacing Amazon, which allowed the index to increase its representation in the pharmaceutical trade.
\n\n\n\nIN BRIEF | \n
| - Walgreens Boots Alliance is a company listed on the NASDAQ under the stock symbol WBA | \n
| - The value of Walgreens stock was $17.85 with a variation of 0.46% to April 15, 2024 | \n
| - Recent performance: share price at $9,361 and declining to $55.67 with a drop in 6.11% | \n
| - Impact on the Dow Jones 30 : the company has a limited weight of 0.44%, among the lowest in the index | \n
| - Sector: part of the sector pharmaceutical with a weight of 0.48% in the index | \n
| - Replacement: In 2018, Walgreens Boots Alliance replaced another company in the Dow Jones | \n
There Walgreens Boots Alliance (WBA) is a key player in the global pharmaceutical sector. As an index member Dow Jones, Walgreens Boots plays a significant role in the fluctuations and dynamics of this prestigious stock index.
\n\n\nRecent developments
\n\n\nThe Walgreens Boots Alliance stock price has gone through several phases over the past few months. On April 15, 2024, the stock was listed at $17.85, recording a slight increase of 0.46% (Source: ZoneBourse). The dynamics of the action highlights a certain volatility, characteristic of current market conditions.
\n\n\nDespite its confirmed presence in the Dow Jones 30 index, Walgreens represents one of the smallest influences with a weight of 0.44%. In comparison, giants such as Verizon and The Coca-Cola Company display weights of 1.16% and 1.05%respectively.
\n\n\nImplications on the Dow Jones
\n\n\nThe Dow Jones Industrial Average measures the performance of the 30 largest companies listed on the stock exchange in the United States. Walgreens Boots joined this index on June 18, 2018, replacing another pharmaceutical company. Its low weighting reflects the increased competitiveness and the presence of other more influential players in the index.
\n\n\nA recent notable development is the replacement of Walgreens by Amazon in the Dow Jones, underscoring the shift toward a more e-commerce and digital services-focused model.
\n\n\nFuture Outlook
\n\n\nStock market analysts are closely watching Walgreens Boots’ performance. Some, such as Paul Johnson, an economic analyst, believe that “diversification of services and strategic strengthening of partnerships could redefine their market position.” The consensus is that strategic expansion could provide new economic opportunities for Walgreens.
\n\n\nFor investors, the question remains how Walgreens will navigate the turbulent waters of the pharmaceutical market, with increasing imperatives for innovation and digitalization.
\n\n\nCritical Analysis
\n\n\nAnalyzing Walgreens Boots Alliance's stock performance, it is clear that the company is facing significant challenges, including intense competition and changes in consumer behavior. However, with the right strategy, focused on innovation and strengthening its digital presence, Walgreens could potentially reverse the trend in its stock performance.
\n\n\n
\nHistory and Positioning of Walgreens Boots Alliance in the Dow Jones
\n\n\nWalgreens Boots Alliance is a leading pharmaceutical company recognized for its extensive network of pharmacies in the United States and internationally. It is listed on the NASDAQ stock exchange under the ticker symbol “WBA”. Since its inclusion in the Dow Jones Industrial Average in 2018, Walgreens Boots Alliance has experienced variable performance, reflecting the challenges and developments in the pharmaceutical distribution industry.
\n\n\nWalgreens Boots' admission to the Dow Jones replaced another major company, reflecting its growing importance on the global economic stage. However, the company's stock market history has been marked by several notable fluctuations. Recently, Walgreens stock recorded one of the worst performances within this index, with its value trading at $55.67, down 6.11% on a given day.
\n\n\nConsidering its influence on the Dow Jones, the company has a relatively low weight of 0.44% in the index, which makes it one of the companies with the least impact in terms of market capitalization among the 30 large companies that make up the Dow Jones. This situation contrasts with companies like Verizon or The Coca-Cola Company, which have more substantial weight.
\n\n\nOver the years, Walgreens Boots has had to adapt to profound transformations in the sector, with the rise of e-commerce and increased pressure from new market players. These dynamics have influenced the company's strategies and its position in the stock market. Currently, Walgreens Boots stock is listed at $17.85, with a slight change in 0.46%, reflecting its relative stability in a volatile market.
\n\n\nIn 2024, the composition of the Dow Jones continues to evolve, and the presence of Walgreens Boots, although less dominant than in its beginnings, remains an important barometer for understanding pharmaceutical sector trends in the American index. Its weight in the Dow Jones is currently stabilizing around 0.48%, an indicator of its position in the sector against potentially more efficient competitors.
\n\n\n\nWalgreens Boots Company Comparison
\n\n\n| Criteria | \nConcise Data | \n
| Stock Market Symbol | \nWBA | \n
| Current Quote (NASDAQ) | \n$9,361 | \n
| Quotation (Source ZoneBourse) | \n$17.85, +0.46% | \n
| Recent performance (Wall Street) | \n$55.67, down 6.11% | \n
| Weight in the Dow Jones | \n0.48% | \n
| Impact on the Dow Jones | \nThe lowest, 0.44% | \n
| Sector of activity | \nPharmaceutical | \n
| Date of entry into the Dow Jones | \nJune 18, 2018 | \n
| Replaced by Amazon | \nImpacts trade exposure | \n
There Walgreens Boots Alliance is a major company in the pharmaceutical sector, listed on the American index Dow Jones. Since its entry into this prestigious list in 2018, the company has stood out for its relatively low weight in the index, with approximately 0.48% in 2024, which reflects its limited impact compared to other market giants.
\n\n\nWalgreens Boots Alliance's flagship products
\n\n\nWalgreens Boots Alliance offers a wide range of products, from prescription drugs to health and beauty products. Among its best-sellers are generic drugs, which are enjoying increasing popularity among consumers looking for more affordable alternatives to branded drugs.
\n\n\nPersonal care products and cosmetics sold under its own brand are also among Walgreens' most popular items. This includes skin care lines and beauty products that appeal to a diverse audience thanks to their accessibility and availability in Walgreens' many points of sale.
\n\n\nWalgreens Boots Alliance's business failures
\n\n\nDespite its successes, Walgreens Boots Alliance has experienced some business failures. A notable example is their attempt at rapid expansion into the international market with some acquisitions that did not bear fruit as hoped. These initiatives often entailed significant costs without commensurate returns.
\n\n\nIn addition, some product innovations or loyalty programs did not generate the desired enthusiasm, limiting their long-term success. However, the company continues to adapt to market and consumer needs to strengthen its position.
\n\n\nAlthough precise sales volumes are not always publicly available for each product, it is clear that Walgreens Boots Alliance's core business remains focused on the retail sale of pharmaceutical and health products, which constitute the majority of its turnover.
\n\n\n\nMajority Shareholders of Dow Jones-listed Walgreens Boots Alliance
\n\n\n| Shareholder | \nParticipation rate (%) | \n
|---|---|
| Vanguard Group | \n7.03% | \n
| BlackRock | \n4.56% | \n
| State Street Corporation | \n3.28% | \n
| Capital Research Global Investors | \n2.84% | \n
| Geode Capital Management | \n1.65% | \n
This table presents the main shareholders of the company Walgreens Boots Alliance and their respective share in the shareholding. These shareholders are important players in the stock market and influence the strategic decisions of the listed company. Dow Jones.
\n\n\n\nI'm sorry, I don't have the data to create a detailed table of dividends paid by Walgreens Boots Alliance with their evolution over time and percentages. However, I can provide you with a descriptive analysis on the company and its positioning in the Dow Jones index.
Walgreens Boots Alliance is a recognized company in the pharmaceutical sector. It is listed on Dow Jones, which is a benchmark index bringing together 30 of the largest companies listed in the United States. Walgreens Boots Alliance appears there, although its weight in this index is relatively low, qualifying at around 0.48% in the composition of the Dow Jones in 2024. This low proportion highlights that the impact of Walgreens Boots on the index is limited compared to other companies.
In terms of recent stock performance, Walgreens has often been in a difficult position within this index. For example, in a recent trading session, Walgreens posted the worst performance on the Dow Jones, with a significant drop of 6.11% and its share price was trading at $55.67. This volatility can influence investors' decisions about dividend prospects.
To track dividends paid by Walgreens Boots Alliance, it is recommended to consult specialized financial resources and analyst reports that provide historical data and forecasts on dividends. This information makes it possible to determine whether the company's dividend distribution strategy is stable or whether it evolves over time.
Walgreens Boots Alliance Company Analysis
\n\n\nWalgreens Boots Alliance is a leading company in the pharmaceutical industry. Listed on NASDAQ under the ticker symbol "WBA", the company plays a significant role in the famous American stock index, the Dow Jones Industrial Average, although its impact is relatively limited compared to other index giants.
\n\n\nIndeed, the weight of Walgreens Boots Alliance in the Dow Jones 30 is modest, representing only 0.48%. This situation reflects its performance on the stock market in recent years. As an example, recently Walgreens Boots stock traded at $17.85, up slightly by 0.46%, but it saw significant swings with a drop of 6.11%, reaching $55.67 at one point.
\n\n\nThe presence of Walgreens in this index symbolizes its importance in the American economy, but it should be noted that this position precedes significant movements in its composition, such as the replacement of Amazon in 2018. These adjustments aim to better reflect market developments and trends.
\n\n\nWalgreens' stock valuation reflects varied analyst perceptions. The general consensus on the company is cautious, due to the challenges it faces in its industry. This perception directly impacts the daily performance of its stock and its positioning within the Dow Jones index.
\n\n\nWalgreens Boots Alliance Company FAQs in the Dow Jones
\n\n\nA: Walgreens Boots’ stock price is currently $17.85 , with a change of 0.46%.A: Walgreens Boots’ ticker symbol is
\n\n\n“WBA” and it is listed on the NASDAQ. A: Walgreens Boots Alliance has a weight of only
\n\n\n0.44% in the Dow Jones, making it one of the companies with the lowest impact on the index. A: Walgreens Boots Alliance has recently been the worst performer in the Dow, trading at $55.67
\n\n\nand a decline of 6.11%. A: Walgreens Boots is a company in the pharmaceuticals sector
\n\n\nwith a weight of 0.48% in the Dow Jones. A: Walgreens Boots Alliance joined the Dow Jones in June 2018, replacing another company in the index.
\n\n\n\n\n
